⌕
Evotec · EVO · Nasdaq
Tenet 51 · Mixed
Compare
$1.56−1.27%At closeTenet 51 · Mixed
$1.56−0.02 (−1.27%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Evotec (EVO) Stock

Evotec (EVO) closed at $1.56 on Nov 16, 2026; its Tenet Score is 51 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$1.56
Nov 16, 2026
Market cap
$554.7M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
1.33 – 3.87
low → high
Tenet Score
51/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Evotec SE scores 51/100. Mixed. Strongest on value, financial health is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
51/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
99
Quality
36
Health
34
Growth
36

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueA+QualityDHealthDGrowthDMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not reported in the company's filings for this period.
P/B
0.6×
cap ÷ fiscal 2025 book value, Nov 13, 2026 close
P/S
0.6×
price to sales
ROE
−13%
fiscal 2025
Operating margin
−7.1%
before interest and tax
Net margin
−13.1%
fiscal 2025
Current ratio
2.07
fiscal 2025
Net debt / EBITDA
—
Withheld: the company's debt is not on file, so leverage is not measured.
EPS CAGR 4y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosi…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 4 US ETFs · top wrappers by weightSee all ETFs holding EVO →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Evotec in?

Evotec is in the Healthcare sector and the Drugs industry.

What is Evotec's Tenet Score?

Evotec's Tenet Score is 51 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.